Russian Prospective Multicenter Registry Study of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke

Conditions

• The Aim the Study is to Collect and Analyze Data on Patients With Acute Ischemic Stroke During Intravenous Thrombolytic Therapy With Alteplase

Interventions

• DRUG: Revelisa

Sponsor

Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health